Is First Solar on the Rebound?
First Solar’s second quarter results were stronger than expected, but we still do not like the solar industry.
Brian Nelson
July Auto Sales Remain Strong But Growth Slows As Comparisons Become Tougher
Auto sales in July continued to grow on a year-over-year basis, but not as quickly as in the first quarter of the year. We still believe Ford and GM are undervalued.
A Slowing Global Economy Can’t Stop Mastercard
Payment processor Mastercard reported excellent second quarter results. We like the firm’s ability to generate value, but we prefer Visa.
Valero Reports Second Quarter Earnings
Valero reported better-than-expected second quarter earnings. However, we think shares are fairly valued.
EDAC Posts 2Q Adjusted EPS of $0.31; Expects Huge Pratt Order in Back Half
Best Idea EDAC Tech posted excellent second-quarter results and hinted at a massive order in its pipeline.
Phillips 66 Reports Fantastic Second Quarter Earnings
Phillips 66 reported much stronger than expected second quarter earnings. We hold the firm in our Dividend Growth Newsletter portfolio.
TRW’s Second Quarter: Another Sign the Auto Recovery Remains On Track
Auto supplier TRW Automotive reported strong second quarter results. We think shares are undervalued at current levels.
Drought Across the US Crushes ADM’s Margins
Drought and weak gasoline demand crushed Archer Daniels Midland’s margins in its fiscal fourth quarter. We think shares are fairly valued.
Coach’s Fourth Quarter Results Hurt by North America
Retailer Coach reported results that were in-line with expectations. However, the road ahead looks choppy.
Pfizer Reports Decent Second Quarter Results; Plans to Spin Off Animal Health Business
Pfizer posted decent second-quarter results that showed strong cost containment in the face of declining sales of its blockbuster drug Lipitor. The company also announced plans to spin off its animal health business to focus on its core pharma business. We maintain our view that Pfizer is significantly underpriced.